PHARMA-TRADE A/S: Financial statements 2023
CVR: 87339815
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMA-TRADE A/S (CVR 87339815) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 34,353,722 compared with DKK 28,014,619 the year before. Equity in the 2023 report amounted to DKK 251,384,578. The solvency ratio was 100%. The company had 177 employees in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 34,353,722
- Equity
- DKK 251,384,578
- Total Assets
- DKK 251,404,578
- Employees
- 177
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | 0 | 34.4M | 251.4M | 177 |
| 2022 | 0 | 0 | 28M | 238.1M | 181 |
| 2021 | 0 | 0 | 46.4M | 242.4M | 196 |
| 2020 | 62K | 4K | 41.1M | 233.2M | 183 |
| 2019 | - | 1.3M | 30.2M | 215M | 192 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMA-TRADE A/S has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK 28,014,619.
About PHARMA-TRADE A/S
PHARMA-TRADE A/S is a Danish company of the type Aktieselskab based in Græsted, founded in 1984. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named PHARMATRADE A/S and FATIMA A/S. The management consists of Henrik Overgaard. The board consists of Jan Overgaard (chair), Henrik Overgaard and Kresten Mikael Valdal. The company is owned by PIF Holding ApS and DANYL FINANS A/S. The company has 3 employees (2019). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 21,231,368 compared with DKK 43,142,185 the year before. Equity in the 2025 report amounted to DKK 254,017,471.